CRISPR Therapeutics CRSP Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by CRISPR Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about CRISPR Therapeutics's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CRISPR Therapeutics's software and technology licenses, net?
- CRISPR Therapeutics (CRSP) reported software and technology licenses, net of $28.98M in Q1 2026.
- How has CRISPR Therapeutics's software and technology licenses, net changed year-over-year?
- CRISPR Therapeutics's software and technology licenses, net increased by 39.5% year-over-year, from $20.78M to $28.98M.
- What is the long-term trend for CRISPR Therapeutics's software and technology licenses, net?
- Over 5 years (2020 to 2025), CRISPR Therapeutics's software and technology licenses, net has grown at a 79.9% compound annual growth rate (CAGR), from $1.29M to $24.37M.